bioRxivBioinformaticsPreprint
Macro-Equi-Diff (MED): Scaffold-based Macrocycles Generation Using Equivariant Diffusion
Sai Shobit KambampatiiD, Siri AnumandlaiD, Sai Lahari GuttulaiD, Varshith Reddy KavadiiD, Sanjana GogteiD, Vani KondaparthiiD
- Citations
- 0
Abstract
Macrocyclic compounds are essential in drug discovery as they can modulate protein-protein interactions and enhance selectivity. Their structural complexity enables access to molecular diversity beyond traditional small molecules; however, designing feasible macrocycles remains a challenging task. Current computational methods often fail to generate macrocycles with proper drug-like properties. Here, we present Macro-Equi-Diff (MED), a deep learning framework that combines transformer-based site identification with an E(3)-equivariant Diffusion Model (EDM) for linker creation, and a fragment-linker attachment module. MED transforms acyclic molecules into structurally consistent macrocycles. MED was tested on the ZINC dataset, achieving high validity (93.92%), uniqueness (99.94%), macrocyclization (99.92%), and linker novelty (82.81%). MED improves upon previous methods that lack a macrocyclic geometry context. As a case study, MED was used to macrocyclize four acyclic drugs targeting the JAK2 protein. The generated macrocycles exhibited favourable molecular descriptors and strong binding affinities, establishing MED as a reliable method for expanding the macrocyclic chemical space.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- MicroED as a powerful tool for structure determination of macrocyclic drug compounds directly from their powder formulations
E. Danelius, G. Bu, … T. Gonen·bioRxiv·Jul 31, 2023
- CyclicCAE: A Conformational Autoencoder for Efficient Heterochiral Macrocyclic Conformational Sampling
Andrew C. Powers, P. Douglas Renfrew, … Vikram Khipple Mulligan·bioRxiv·Feb 21, 2025
- DrugDiff - small molecule diffusion model with flexible guidance towards molecular properties
Marie Oestreich, Erinç Merdivan, … Matthias Becker·Journal of CheminformaticsPeer-reviewed·Feb 25, 2025
- Rigid Scaffolds are Promising for Designing Macrocyclic Kinase Inhibitors
Zheng Zhao, Philip E. Bourne·ACS Pharmacology & Translational SciencePeer-reviewed·Jul 7, 2023
- Expanding Macrocyclic Topology through Cysteine-to-N-Terminal Cyclisation Enables Covalent Peptide Inhibitor Discovery
Ella Sawtell, Marina Barrueco, … Scott Lovell·bioRxiv·Sep 8, 2026
- MedSAGE: Bridging Generative AI and Medicinal Chemistry for Structure-Based Design of Small Molecule Drugs
Alexander S. Powers, Tianyu Lu, … Ron O. Dror·bioRxiv·May 10, 2025